MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
+22.91%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$777M
AUM Growth
+$777M
(+18%)
Cap. Flow
-$26.5M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$1.84M |
Top Sells
| 1 |
Exelixis
EXEL
|
$28.3M |
Sector Composition
| 1 | Healthcare | 93.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $501M | 64.5% | 16,484,638 -932,100 | -5% | -$28.3M |
|
|
2
Esperion Therapeutics
ESPR
$448M
| $153M | 19.68% | 2,322,835 +27,900 | +1% | +$1.84M |
|
3
Alkermes
ALKS
$4.78B
| $56.4M | 7.26% | 1,030,639 | – | – |
|
4
Celldex Therapeutics
CLDX
$1.47B
| $17.9M | 2.31% | 6,312,700 | – | – |
|
5
ProShares UltraPro Short S&P 500
SPXU
$527M
| $14M | 1.8% | 1,230,000 | – | – |
|
6
ProShares UltraShort S&P500
SDS
$445M
| $12.9M | 1.66% | 315,000 | – | – |
|
7
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $11.1M | 1.43% | 400,000 | – | – |
|
8
iShares MSCI India ETF
INDA
$9.17B
| $10.5M | 1.35% | 290,000 | – | – |
|